Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 3 1

Status

Withdrawn 1Unknown 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1Classical hematology 1

Conditions

Venous Thromboembolism 1Thrombosis 1Thrombophilia 1Thromboembolism 1Small Cell Lung Carcinoma 1Sarcoma 1Pulmonary Embolism 1Multiple Myeloma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Esophageal Neoplasms 1Digestive System Diseases 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1198Oxaliplatin 1160Capecitabine 1142Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Interventional × enoxaparin sodium × Clear all
NCT07270263 2025-12-26

HEM-DOAC

Medical University of Gdansk

Phase NA Recruiting
100 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Hematologic Neoplasms, Venous Thromboembolism

NCT06153394 2024-04-23

PRIORITY

Western University, Canada

Phase 3 Not yet recruiting
50 enrolled

Digestive System Diseases, Thrombosis, Thrombophilia

NCT01696760 2018-12-05

Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology

Ohio State University Comprehensive Cancer Center

Phase NA Completed
12 enrolled 6 charts
Sarcoma

Sarcoma, Thromboembolism

NCT03254511 2017-08-22

Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer

Mashhad University of Medical Sciences

Phase 2 Unknown
100 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00916669 2013-05-08

A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)

Massachusetts General Hospital

Phase 2 Withdrawn
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡